JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JVI Accepts, published online ahead of print on 23 August 2006
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.01119-06v1
80/21/10565    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hargett, D.
Right arrow Articles by Bachenheimer, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hargett, D.
Right arrow Articles by Bachenheimer, S. L.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.01119-06
Copyright (c) 2006, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

HERPES SIMPLEX VIRUS TYPE 1 ICP27-DEPENDENT ACTIVATION OF NF{kappa}B

Danna Hargett, Stephen Rice, and Steven L. Bachenheimer*

Department of Microbiology and Immunology, and Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC 27599-7290, Department of Microbiology, University of Minnesota Medical School, Mayo Mail Code 196, 420 Delaware Street SE, Minneapolis, MN 55455

* To whom correspondence should be addressed. Email: bachlab{at}med.unc.edu.


   Abstract

The ability of herpes simplex virus type 1 (HSV-1) to activate NF{kappa}B has been well documented. Beginning at 3-5 h post infection, HSV-1 induces a robust and persistent nuclear translocation of an NF{kappa}B-dependent (p50/p65 heterodimer) DNA binding activity, as measured by EMSA. Activation requires virus binding and entry, as well as de novo infected cell protein synthesis and is accompanied by loss of both I{kappa}B{alpha} and I{kappa}B{beta}. In this study we identified loss of I{kappa}B{alpha} as a marker of NF{kappa}B activation, and infection with mutants deleted for individual immediate-early (IE) regulatory proteins indicated that ICP27 was necessary for I{kappa}B{alpha} loss. Analysis of both N-terminal and C-terminal mutants of ICP27 identified the region from aa21-63 as necessary for I{kappa}B{alpha} loss. Additional experiments with mutant viruses deleted for combinations of IE genes, revealed that the ICP27-dependent mechanism of NF{kappa}B activation may be augmented by functional ICP4. We also analyzed two additional markers for NF{kappa}B activation, phosphorylation of the p65 subunit on ser276 and ser536. Phosphorylation of both serines was induced upon HSV infection, and required functional ICP4 and ICP27. Pharmacological inhibitor studies revealed that both I{kappa}B{alpha} and ser276 phosphorylation were dependent on JNK kinase activity, while ser536 phosphorylation was not affected during inhibitor treatment. These results demonstrate that there are several layers of regulation of NF{kappa}B activation during HSV infection, highlighting the important role that NF{kappa}B may play in infection.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.